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Abstract
Protozoan pathogens of the genus Leishmania have evolved unique signaling mechanisms that can sense changes in the
host environment and trigger adaptive stage differentiation essential for host cell infection. The signaling mechanisms
underlying parasite development remain largely elusive even though Leishmania mitogen-activated protein kinases
(MAPKs) have been linked previously to environmentally induced differentiation and virulence. Here, we unravel highly
unusual regulatory mechanisms for Leishmania MAP kinase 10 (MPK10). Using a transgenic approach, we demonstrate that
MPK10 is stage-specifically regulated, as its kinase activity increases during the promastigote to amastigote conversion.
However, unlike canonical MAPKs that are activated by dual phosphorylation of the regulatory TxY motif in the activation
loop, MPK10 activation is independent from the phosphorylation of the tyrosine residue, which is largely constitutive.
Removal of the last 46 amino acids resulted in significantly enhanced MPK10 activity both for the recombinant and
transgenic protein, revealing that MPK10 is regulated by an auto-inhibitory mechanism. Over-expression of this hyperactive
mutant in transgenic parasites led to a dominant negative effect causing massive cell death during amastigote
differentiation, demonstrating the essential nature of MPK10 auto-inhibition for parasite viability. Moreover, phosphopro-
teomics analyses identified a novel regulatory phospho-serine residue in the C-terminal auto-inhibitory domain at position
395 that could be implicated in kinase regulation. Finally, we uncovered a feedback loop that limits MPK10 activity through
dephosphorylation of the tyrosine residue of the TxY motif. Together our data reveal novel aspects of protein kinase
regulation in Leishmania, and propose MPK10 as a potential signal sensor of the mammalian host environment, whose
intrinsic pre-activated conformation is regulated by auto-inhibition.
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Introduction
Leishmaniasis is an infectious disease characterized by a variety
of pathologies, affecting more than 12 million people worldwide
and ranging from self-healing cutaneous lesions to fatal visceral
infection [1]. This disease is caused by pathogenic protozoa of the
genus Leishmania, which show two major life cycle stages
depending on the host. The extracellular promastigote stage
develops inside the midgut of sandflies and is transmitted during
blood feeding to a vertebrate host where they are ingested by
phagocytic cells, notably macrophages. Inside the host cell
phagolysosome, promastigotes develop into proliferating intracel-
lular amastigotes. These developmental transitions are triggered by
environmental changes, mainly pH (7.4 to 5.5) and temperature
(26uC to 37uC), encountered in insect and vertebrate hosts,
respectively, and can be mimicked in vitro [2–4]. Interfering with
amastigote stage development and proliferation by altering the
parasite’s ability to sense its environment could be a very efficient
way to eliminate intracellular Leishmania and thus signaling
proteins involved in extra- or intracellular signal transduction are
interesting drug target candidates.
In eukaryotes, environmental signals are generally sensed and
transduced by signaling cascades involving receptors and down-
stream-regulated protein kinases. The MAPK signaling pathway is
a good example of such a phosphorylation cascade [5] as it is
composed of mitogen-activated protein kinase kinase kinases
(M3Ks), which activate mitogen-activated protein kinase kinases
(M2Ks), which in turn activate mitogen-activated protein
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kinases (MAPKs) by dual phosphorylation on the highly conserved
TxY motif present within the MAPK activation loop [6,7].
MAPKs regulate various important cellular functions, such as cell
cycle progression and differentiation, through phosphorylation of a
large number of substrates, including transcription factors and
MAPK-activated protein kinases, thus modifying gene expression
and post-translational regulation, respectively [8–14]. While the
core cascade M3K-M2K-MAPK is conserved in Leishmania, the
absence of classical transcription factors and the largely constitu-
tive gene expression suggest that the response to environmental
signals occurs mainly post-translationally through the regulation of
the level of protein phosphorylation, rather than through
modulation of gene expression [15].
As in higher eukaryotes, the Leishmania MAPK pathway
comprises two distinct kinase families, the STE family, which
includes five putative M2K and M2K-like and 20 putative M3K
members, and the CMGC family, including 17 putative MAPK
and MAPK-like members [16]. The comparison between the
Leishmania major and the human kinomes revealed an evolution-
ary expansion relative to genome size of these two kinase families
in the parasite. The STE and CMGC families represent 19% and
25% in the Leishmania kinome, compared to 9% and 12% in the
human kinome, respectively [17]. These expansions indicate that
the MAPK pathway could be of particular importance to parasite
development and survival, a possibility that is supported by recent
investigations showing that Leishmania MAP kinases are required
for flagellar development, intracellular survival and viability
[16,18–23]. Thus, the study of Leishmania MAPKs could hold
the key to the understanding of the mechanisms that allow the
adaptation of Leishmania to environmental changes required for
extra- and intracellular parasite survival during host infection.
The activity of the three Leishmania MAPKs MPK4, MPK7
and MPK10 have been shown to be induced in a stage-specific
manner in axenic amastigotes, which occurred concomitant to an
increase of their phosphorylation as expected for this class of
kinases [24–26]. The importance of MPK4 and MPK7 for cell
survival and infectivity, respectively, has been established
[21,26,27], but neither the mode of regulation nor the functions
of MPK10 have been studied. MPK10 is conserved in all
Leishmania species (Figure S1A) with a percentage of identity
above 90%. This percentage is even higher if we compare the
sequence of L. donovani MPK10 with that of L. major, L.
mexicana and L. infantum (99%, 98% and 100%, respectively,
Figure S1B). The close relationship between this kinase and
human ERK2 or p38 kinase suggests a potential role in cell
differentiation or in response to stress [28,29]. Leishmania MPK10
is a highly conserved member of the eukaryotic MAPK family.
However, MPK10 does not resemble a classical eukaryotic MAPK
with respect to two structural features. First, the alignment of the
protein sequence with its mammalian orthologs revealed the
presence of a long carboxy-terminal extension [16,24]. This is a
common feature for Leishmania MAPKs (observed in 15 out of 17
putative Leishmania MAPKs), whereas only five mammalian
MAPKs have such an extension. They are usually regulatory
domains implicated in the control of the kinase activity,
localization or auto-inhibition [30–34]. Second, a structural
analysis of MPK10 published recently by Horjales et al. provided
evidence that recombinant MPK10 adopts an activated confor-
mation, despite the absence of TxY phosphorylation [29].
Following phosphorylation of this motif by upstream M2Ks,
mammalian MAPKs are activated by the switch of a conserved
DFG motif from an inactive (DFG-out) to an active (DFG-in)
conformation. This change leads to the alignment of two structural
motifs comprising non-consecutive hydrophobic residues that are
referred to as the regulatory and catalytic spines [35,36]. In
contrast to mammalian MAPKs, the Leishmania DFG motif of
MPK10 is replaced by DFN, causing the R and C spines to be
aligned thus stabilizing an apparent active conformation in the
absence of TxY phosphorylation [29]. These findings suggest that
MPK10 has a strikingly different mode of regulation compared to
mammalian MAPKs, which could be particularly adapted to
adjust quickly to environmental changes thus acting as a signaling
switch.
Here, by utilizing a transgenic approach we unraveled an
unusual mechanism of MPK10 regulation that tightly controls
kinase activity. Stage-specific increase in MPK10 activity during
the pro- to axenic amastigote conversion did not follow the largely
constitutive phosphorylation status of the regulatory tyrosine
residue in the kinase activation loop, suggesting additional and
non-classical mechanisms of MPK10 regulation. Combining
limited tryptic digestion with mutagenesis analysis and phospho-
proteomics investigation, we uncovered an essential role of the C-
terminal domain of MPK10 in limiting stage-specific kinase
activity, and identified a novel regulatory phospho-serine residue
that is required for axenic amastigote viability. Together our data
propose MPK10 as a potential signal sensor of the mammalian
host environment whose intrinsic pre-activated conformation is
regulated by auto-inhibition. These results shed important new
light on Leishmania-specific signaling mechanisms, and signifi-
cantly advance our understanding on parasite-specific protein
kinase biology.
Results
Recombinant MPK10 shows no significant substrate-
specific kinase activity
To investigate the biochemical properties of MPK10, we
generated non-mutated recombinant MPK10 (NM) and the
corresponding MPK10-K51A enzymatically dead mutant, both
tagged with GST-Strep. We used the bacterially expressed and
purified proteins in an in vitro kinase assay at 30uC or 37uC,
monitoring the transfer of radiolabeled phosphate from c-33P-ATP
to MPK10 (auto-phosphorylation) or to the canonical MAPK
substrate myelin basic protein (MBP) [37–39]. The kinase
reactions were subjected to SDS-PAGE, proteins were visualized
by Coomassie staining for normalization (Figure 1A, upper
panel), and phosphotransferase activity was revealed by auto-
radiography (Figure 1A, lower panel). We observed a weak auto-
phosphorylation signal at 30uC that was slightly enhanced when
Author Summary
Leishmaniasis is an important human disease caused by
Leishmania parasites. A crucial aspect of Leishmania
infectivity is its capacity to sense different environments
and adapt for survival inside insect vector and vertebrate
host by stage differentiation. This process is triggered by
environmental changes encountered in these organisms,
including temperature and pH shifts, which usually are
sensed and transduced by signaling cascades including
protein kinases and their substrates. In this study, we
analyzed the regulation of the Leishmania mitogen-
activated protein kinase MPK10 using protein purified
from transgenic parasites and combining site-directed
mutagenesis and activity tests. We demonstrate that this
kinase is activated during parasite differentiation and
regulated by an atypical mechanism involving auto-
inhibition, which is essential for parasite viability.
L. donovani MPK10 Auto-inhibition
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the kinase reaction was performed at 37uC (Figure 1A, lower
panel). We did not observe any significant activity towards MBP at
both temperatures. Likewise, performing kinase assays at 37uC
and pH 7.5 with other substrates, including casein, histone H1 or
Ets1, revealed only a very weak substrate-specific activity, with
casein giving rise to the strongest signal, which still was faint
compared to the levels of auto-phosphorylation (Figure 1B, lower
panel). By contrast, recombinant human MEK1 (a M2K), used as
a positive control, revealed strong substrate-specific activity
towards MBP. No substrate phosphorylation or auto-phosphory-
lation could be detected with the kinase dead MPK10-K51A
control, suggesting that the signals observed were specific for
MPK10 and not due to a co-purified bacterial kinase. Based on
these results, casein appears to be the most suitable substrate for
recombinant MPK10.
We next varied the pH of the kinase assay in an attempt to
improve MPK10 activity. Kinase assays performed with casein
and MPK10 or MPK10-K51A at pH 5.5, 6.5, 7.5 and 8.5
revealed different pH optima for auto- and substrate-specific
phosphorylation at pH 6.5 and 7.5, respectively (Figure S2, lower
panel). In conclusion, recombinant MPK10 shows some minor
auto-phophorylation activity, but largely fails to phosphorylate the
canonical MAPK substrate MBP [37–39], which may either
depend on activation through an upstream M2K, parasite-specific
kinase substrate interactions, or auto-inhibition.
Deletion of a C-terminal domain increases MPK10 kinase
activity
We performed a limited tryptic digestion of purified recombi-
nant GST-Strep-tagged MPK10 to investigate the presence of
potential auto-inhibitory accessory domains by delineating the
structured, protease-resistant kinase core. We treated recombinant
MPK10 with 0.25 mg of trypsin for 150 minutes, analyzing
samples after 2.5, 5, 15, 30, 60 and 150 minutes by SDS-PAGE
and Coomassie staining. MPK10 was sensitive to partial digestion
as we observed the appearance of several bands within the first
15 minutes corresponding to different tryptic MPK10 products
(Figure 2A). After 30 min of treatment, only one band remained,
revealing the core of the kinase. N-terminal sequencing and
SELDI-TOF analysis of four of the digestion products (as marked
by arrowheads in Figure 2A and represented by the cartoon
shown in Figure 2B) revealed that both ends of the tagged protein
were cleaved by trypsin at lysines 12, 24, and 30, arginine 392. We
also identified a digestion product that resulted from cleavage at
aspartate 387 and thus lacked the last 46 amino acids of MPK10
(Figure 2C). This product is likely due to a miscleavage or cleavage
by a contaminating bacterial protease.
To investigate the activity of the MPK10 kinase core alone and
to test whether deletion of the C-terminal region (46 aa) increases
its activity, we generated and purified recombinant non-mutated
His6-MPK10 (NM) or mutated His6-MPK10 deleted for the last
46 amino acids (DC) and monitored their activity towards
canonical substrates by performing in vitro kinase assays in the
presence of c-33P-ATP. We changed from the GST-Strep to His6
tag to show that the lack of MPK10 substrate phosphorylation
activity is independent from this modification. The auto-
radiogram shown in Figure 2D (left panel) confirms weak auto-
and substrate phosphorylation activity of His6-MPK10 NM similar
to GST-STREP-MPK10 NM ruling out tag-specific interference
with kinase activity. In contrast to His6-MPK10 NM, His6-
MPK10-DC presented a stronger auto-phosphorylation activity
and enhanced phosphorylation of Ets1 and casein. These
Figure 1. Recombinant MPK10 shows no significant substrate-specific kinase activity. In vitro kinase assays using non-mutated GST-Strep-
MPK10 (NM) and the corresponding inactive mutant GST-Strep-MPK10-K51A (K/A). Analysis of the reaction samples was performed by SDS-PAGE, gels
were stained with Coomassie (upper panels) and phosphotransfer was visualized by auto-radiography (lower panels). All gels are representative of
three independent experiments. (A) Purified GST-Strep-MPK10 NM was incubated with (+) or without (2) the canonical MAPK substrate MBP for
30 min at pH 7.5 and 30uC or 37uC. (B) GST-Strep-MPK10 NM and -K/A were incubated with different canonical substrates, including 12 mg of histone
H1, 9 mg of Ets1, 36 mg of casein, and 25 mg of MBP. Recombinant human MEK1 was used as positive control with MBP as substrate. Kinase assays
were performed for 30 min at pH 7.5 and 37uC.
doi:10.1371/journal.ppat.1004347.g001
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differences reflect a true increase in phosphotransferase activity as
judged by Coomassie staining, which showed equal loading of
both recombinant proteins and substrates (Figure 2D, right panel).
The signals were specific for His6-MPK10-DC and not caused by a
co-purified kinase, as we did not detect any signal with the His6-
MPK10-DC_K51A control. Yet again, the auto-phosphorylation
signals of NM or truncated MPK10 were significantly stronger
than those for substrate phosphorylation. Moreover, no 33P
incorporation could be detected for MBP. Thus, deleting the C-
terminal tail substantially increases the ability of MPK10 to
phosphorylate itself, suggesting a potential role of this domain in
negative regulation. The C-terminal domain of L. donovani
MPK10 is conserved in Leishmania species (84 to 100%, Figure
S3B) but not in Trypanosoma species (38 to 53%, Figure S3B),
except for the conserved motif (DHMxRTxSxME), of unknown
function (underlined, Figure S3A). This motif is only conserved in
trypanosomatid MPK10 as extending the analysis of the C-
terminal extensions to the 14 Leishmania and 2 human MAPKs
Figure 2. Deletion of the C-terminal domain increases auto-phosphorylation activity. (A) Partial tryptic digestion of recombinant MPK10.
50 mg of Strep3-MPK10 were digested with 0.25 mg trypsin at RT. Aliquots were taken at the indicated time points and the reaction was stopped
either by adding Laemmli buffer (for N-terminal sequencing) or by lowering the pH to 5.0 and subsequent freezing (for mass determination by SELDI-
TOF). For N-terminal sequencing, samples were separated by SDS-PAGE, transferred on PVDF membrane and stained by amidoblack. N-terminal
sequencing was performed at the protein analysis platform at the Institut Pasteur. For mass determination, samples were immobilized on a H4
ProteinChip Array (C16 reversed phase surface) and peptide masses identified by SELDI-TOF. Results of the N-terminal sequencing are represented by
the cartoon in (B), and the sequences are indicated in (C). Italic characters represent the Strep3-tag and bold characters represent the sequence of
Leishmania major MPK10. White and grey arrowheads indicate respectively lysine or arginine residues recognized by trypsine, including K12, K24, K30
and R392. The white arrow at the position D387 indicates the position of the last cleaved residue resulting in the generation of the form lacking the
last 46 amino acids of MPK10. (D) In vitro kinase assay using recombinant His-MPK10 (NM) and the truncated kinase mutants His-MPK10-DC (DC), and
His-MPK10-DC_K51A (DC_K/A). Results are representative of three independent experiments. Purified proteins were incubated with four different
substrates, including 12 mg of histone H1, 9 mg of Ets1, 36 mg of casein, and 25 mg of MBP. Recombinant human MEK1 was used as positive control
with MBP as substrate. Kinase assays were performed at the same time for 30 min at pH 7.5 and 37uC and reaction samples were separated by SDS-
PAGE, gels were stained by Coomassie (right), and signals were revealed by auto-radiography with the same exposure time between the different
gels (left). The brackets in (D) indicate auto-phosphorylation (Auto-P) and substrate phosphorylation (Substrate-P) signals.
doi:10.1371/journal.ppat.1004347.g002
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(ERK5 and ERK8) as well as T. brucei TbECK1 [32] by pattern
recognition analysis (Pratt version 2.1) and multiple sequence
alignment (ClustalW) did not reveal this motif or any other
conserved motifs or patterns (data not shown). As our study reveals
important limitations of the bacterially expressed protein with
regard to kinase activity, we analyzed in the following in situ
activated MPK10 isolated from transgenic L. donovani parasites.
MPK10 activity is substantially increased during axenic
amastigote differentiation
To gain insight into MPK10 regulation and activity in a
physiologically relevant context, we generated transgenic parasites
expressing a GFP-MPK10 fusion protein from the episomal vector
pXG-GFP2+ (kindly provided by S. Beverley). We first performed
a time course experiment to investigate MPK10 activity in
promastigotes and during axenic amastigote differentiation. GFP-
MPK10 was purified using a monoclonal anti-GFP antibody from
L. donovani promastigotes harvested from logarithmic (log) or
stationary (stat) phase cultures, and from cultures at different time
points between 12 h to 120 h after induction of axenic amastigote
differentiation by pH and temperature shift. Immuno-purified
proteins were incubated for 30 min at 37uC in the presence of
radiolabeled ATP and MBP, and the kinase reaction was subjected
to SDS-PAGE. The phosphotransferase activity was determined
by auto-radiography (Figure 3A, a and b), and MPK10 and MBP
were visualized by Coomassie staining for normalization
(Figure 3A, c and d). After exposure, the bands corresponding to
the signals of phosphorylated MPK10 or MBP were recovered
from the dried gel and 32P incorporation was measured using a
scintillation counter. The results were expressed relative to GFP-
MPK10 NM from promastigotes of logarithmic culture set to
100% (the relative counts are represented by the numbers in
Figure 3A a and b). As opposed to recombinant MPK10 we
observed that MBP phosphorylation was higher than MPK10
auto-phosphorylation when using protein purified from parasite
extracts. This finding suggests that the purification of GFP-
MPK10 from transgenic parasites allows the assessment of
biologically relevant kinase activity. MPK10 purified from
parasites undergoing axenic amastigote differentiation showed a
higher level of MBP phosphorylation compared to promastigotes,
especially during the first 48 h following temperature and pH shift
(202% versus 100% respectively, Figure 3A, b). Afterwards, the
level of activity decreases to reach its lowest point at 96 h (31%),
and increases again at 120 h (144%). These data suggest that
MPK10 activity is stage-specifically regulated. The signals
observed are specific to MPK10 and not due to a co-purified
kinase as no signals were observed with the K51A mutant (data
not shown).
The mean values with standard deviation of three independent
experiments are represented by the histogram plot shown in
Figure 3B. As judged by statistical analysis (see Figure S4),
significant differences in MPK10 kinase activity are observed (i)
between promastigotes and parasites at 48 h of axenic amastigote
differentiation confirming its stage-specific regulation, (ii) between
parasites at 48 h and 72 h or 96 h, demonstrating a transient
reduction in MPK10 activity during later stages of axenic
differentiation, and (iii) between parasites at 96 h and 144 h
providing evidence for a second peak in MPK10 activity in axenic
amastigotes. Conversely, no significant difference in MPK10
activity was observed between promastigotes from logarithmic or
stationary phase culture.
Phosphorylation of both the threonine and the tyrosine residues
of the TxY motif have been shown to be required for eukaryotic
MAPK activation and dual phosphorylation is correlated with
kinase enzymatic activity. As an alternative read out for MPK10
activity we therefore assessed tyrosine phosphorylation using an
anti-phosphotyrosine antibody. First, we tested whether phos-
phorylated Tyr192 was the only residue recognized by the
antibody in MPK10. We compared the signals obtained with
GFP-MPK10 NM, GFP-MPK10-K51A and the corresponding
TxY motif mutants T190A, Y192F and T190A_Y192F purified
from respective transgenic promastigotes harvested in logarithmic
growth phase (low level of MPK10 activity, Figure 3B), or cells
during axenic amastigotes differentiation harvested at 48 h after
induction of differentiation (high level of MPK10 activity,
Figure 3Ab and B). The western blot presented in Figure 3C
shows that GFP-MPK10 NM, GFP-MPK10-K51A and GFP-
MPK10-T190A are recognized by the anti-phosphotyrosine
antibody as documented by the detection of a strong signal at
75 kDa (Figure 3C). The absence of this signal in GFP-MPK10-
Y192F and GFP-MPK10-T190A_Y192F demonstrates that
pY192 is the only residue recognized by this antibody in GFP-
MPK10. Moreover, Y192 phosphorylation does not require T190
phosphorylation as Y192 is phosphorylated in the GFP-MPK10-
T190A single mutant. Remarkably, we did not observe any
difference in the level of tyrosine phosphorylation between
MPK10 purified from log promastigotes or from 48 h axenic
amastigotes despite their difference in activity, suggesting that the
phosphorylation state of Y192 is dissociated from the regulation of
kinase activity. In contrast, no tyrosine phosphorylation was
observed for recombinant MPK10 NM, which further supports
the observed inactive state of the bacterially purified kinase
(Supplementary Figure S5).
We next studied dissociation of MPK10 activity and Y192
phosphorylation state in a more detailed time course experiment
by western blot analysis of pY192 levels in promastigotes (log and
stat) and during axenic amastigote differentiation (Figure 3D).
Again, no difference was observed in the phosphorylation state of
Y192 between MPK10 purified from log promastigotes, stat
promastigotes or axenic amastigotes during the first 48 h of
differentiation, despite their significant differences in activity. After
72 h we observed a decrease in tyrosine phosphorylation, which
this time correlated with decreased MPK10 activity.
These findings were supported by an independent experiment
performed with Leishmania mexicana using a targeted quantitative
phosphoproteomic analysis termed Selected Reaction Monitoring
(SRM, [40]), from which results concerning MPK10 were extracted
and presented in Figure 3E. In this analysis the phosphorylation
states of the two regulatory phosphorylation sites T190 and Y192
were quantified in L. mexicana late log phase promastigotes and
axenic amastigotes at 72 h of differentiation. Peptides containing
T190-H-pY192 (unphosphorylated T190 and phosphorylated
Y192) were found at similar levels in promastigotes and axenic
amastigotes, whereas peptides containing pT190-H-pY192 (pT190
and pY192 dual phosphorylation) showed significantly increased
abundance in the axenic amastigote fraction. Peptides containing a
single pT190 phosphorylation were not detected. These results
show that phosphorylation of T190 and Y192 occurs independent-
ly: while pY192 is identified both in promastigotes and in axenic
amastigotes, pT190 is mostly identified in amastigotes and thus this
phosphorylation event may be the rate limiting step for MPK10
activation. Altogether, these findings strongly suggest that the
phosphorylation of the Y192 residue is largely constitutive and
occurs independently from MPK10 activation, which is in contrast
to MAPK regulation in most other eukaryotes. This characteristic of
MPK10 is likely a conserved feature among Leishmania species as
we found similar results with independent experiments performed
with L. donovani and L. mexicana.
L. donovani MPK10 Auto-inhibition
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Both threonine 190 and tyrosine 192 are required for
MPK10 activity
In most eukaryotes, both residues of the TxY motif need to be
phosphorylated for MAPK activation and as a consequence their
mutation abrogates kinase activity [41–43]. To analyze the
requirement of T190 and Y192 phosphorylation for MPK10
activity, we used our transgenic cell lines to investigate the impact
of the overexpression of the three different MPK10 TxY-motif
mutants on parasite growth and survival as well as to measure
MPK10 kinase activity, using GFP-MPK10 and GFP-MPK10-
K51A as positive and negative controls, respectively. We first
followed the growth and percentage of cell death in promastigotes
by flow cytometry analysis and observed no differences between
the untransfected L. donovani control (UC) and parasites over-
expressing GFP-MPK10 NM or mutant forms (Figure S6). We
next measured the kinase activity of GFP-MPK10 NM and GFP-
MPK10 mutant proteins purified from promastigotes. The results
presented in Figure 4A show that GFP-MPK10 NM undergoes
weak auto-phosphorylation (exposure 3 h), but catalyzes robust
MBP phosphorylation (exposure 1 h). It is interesting to note that
although the auto-phosphorylation signals are much weaker than
the MBP phosphorylation signals, they are similarly regulated. No
MBP phosphorylation could be detected with the GFP-MPK10-
K51A, -T190A, -Y192F or -T190A_Y192F mutants. These data
demonstrate that, similarly to other eukaryotic MAPKs, T190 and
Y192 are essential for MPK10 activity, as their mutation
considerably reduced the activity of the kinase.
Figure 3. MPK10 activity is enhanced during axenic amastigote
differentiation. (A) In vitro kinase assay. GFP-MPK10 NM fusion
protein was purified using anti-GFP antibody from logarithmic (Log)
and stationary (Sta) growth phase promastigotes (Pro) and after 12 h,
24 h, 36 h, 48 h, 72 h, 96 h and 120 h of axenic amastigote (Ax. ama.)
differentiation. Kinase assays were performed for 30 min at 37uC with
25 mg of MBP as substrate. Reaction samples were separated by SDS-
PAGE, gels were stained with Coomassie (Coom.), and signals were
revealed by auto-radiography (Auto-rad.) using the indicated exposure
time. The numbers represent the level of radioactive counts as
determined in a scintillation counter. The results were expressed
relative to GFP-MPK10 NM from promastigotes of logarithmic culture
set to 100%. (B) Signal quantification. The histogram plot represents the
level of radioactive counts as determined in a scintillation counter. The
results were expressed relative to GFP-MPK10 NM from promastigotes
of logarithmic culture set to 100%. Histograms represent mean values
and the error bars correspond to the standard deviation of three
independent experiments. Statistical significance was calculated by t-
test or Mann-Whitney Rank Sum test. (C) Assessment of tyrosine
phosphorylation. Non-mutated GFP-MPK10 (NM), and mutated GFP-
MPK10-K51A (K/A), -Y192F (Y/F) and -T190A_Y192F (T/A_Y/F) were
purified from promastigote (Pro.) and axenic amastigote (Ax. ama.) after
48 h of differentiation, and analyzed by western blotting using anti-
phospho-tyrosine (a-pTyr) and anti-MPK10 (a-MPK10). (D) Analysis of
tyrosine phosphorylation during axenic amastigote differentiation.
Samples used in (A) were analyzed by western blotting using mouse
anti-phospho-tyrosine (a-pTyr) and rabbit anti-MPK10 (a-MPK10)
antibodies. (E) SRM analysis. Digested proteins from whole cell lysates
of L. mexicana promastigotes (Pro) and axenic amastigotes (Ax. Ama),
were subjected to TiO2 enrichment, eluates were desalted on C8 STAGE-
tips and vacuum dried. Prior to LC-MS/MS analysis, the eluates were
reconstituted in 0.1% formic acid. The acquired data were imported into
the Pinpoint method file for analysis. T-H-pY, peptides represent single
phosphorylation of Y192; pT-H-pY, peptides represent dual phosphor-
ylation of residues T190 and Y192. This value of T-H-pY represents the
sum of the values obtained with two different peptides (THYVTHR and
EDTADANKTHYVTHR). All blots and auto-radiograms are representative
of three independent experiments.
doi:10.1371/journal.ppat.1004347.g003
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Figure 4. Both threonine 190 and tyrosine 192 are required for MPK10 activity. (A) In vitro kinase assay. Purified protein from
promastigotes expressing non-mutated GFP-MPK10 (NM), and mutated GFP-MPK10-K51A (K/A), -T190A (T/A), -Y192F (Y/F) and -T190A_Y192F (T/A_Y/
F) were incubated for 30 min at 37uC and pH 7.5 with 25 mg MBP as substrate. Reaction samples were separated by SDS-PAGE, gels were stained by
Coomassie (Coom.), and signals revealed by auto-radiography (Auto-rad.) using the indicated exposure time. The numbers represent the level of
radioactive counts as determined in a scintillation counter. The results were expressed relative to GFP-MPK10 NM from promastigotes of logarithmic
culture set to 100%. Results are representative of three independent experiments. (B) Proliferation and viability analysis. 16106 amastigotes were
cultured for 8 days and aliquots were taken every 24 h for analysis. Cell number and percent of cell death were assessed by flow cytometry. Upper
panel: Untransfected Control, UC (dotted line, open squares); non-mutated GFP-MPK10, NM (grey line, grey circles); GFP-MPK10-K51A, K/A (black line,
open triangles). Lower panel: GFP-MPK10-T190A, T/A (black line, black triangles); GFP-MPK10-Y192F, Y/F (black line, white diamonds); GFP-MPK10-
T190A_Y192F, T/A_Y/F (black line, black diamonds). Mean values of the results obtained in two independent experiments in triplicate were plotted,
with standard deviations indicated by the bars. (C) In vitro kinase assay. Non-mutated GFP-MPK10 (NM), and mutated GFP-MPK10-K51A (K/A), -T190A
(T/A), -Y192F (Y/F) and -T190A_Y192F (T/A_Y/F) obtained from amastigotes at 48 h (left) and 96 h (right) during axenic differentiation were incubated
for 30 min at 37uC and pH 7.5 with 25 mg MBP as substrate. Reaction samples were separated by SDS-PAGE, gels were stained by Coomassie (Coom.),
and signals revealed by auto-radiography (Auto-rad.) using the indicated exposure time. The numbers represent the level of radioactive counts as
determined by a scintillation counter. The results were expressed relative to GFP-MPK10 NM from promastigotes of logarithmic culture set to 100%.
Results are representative of three independent experiments.
doi:10.1371/journal.ppat.1004347.g004
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Threonine 190 mutation affects axenic amastigote
survival
We next investigated the impact of these MPK10 mutants on
amastigote growth and survival. As presented in Figure 4B (upper
panels), untransfected control (UC) parasites showed a decrease in
cell growth during the first 24 hours of differentiation, but started
to grow thereafter to reach a plateau at around 96 h. This profile
was the consequence of a high level of cell death at 24 h
(26613%), which decreased to reach a percentage of cell death of
1562% at 96 h. This phenomenon has been previously
documented and is likely due to the adaptation of parasites to
elevated temperature and acidic pH [44]. Parasites overexpressing
GFP-MPK10 NM (Figure 4B, upper panels) resumed growth after
48 h of differentiation to finally reach the same cell concentration
than UC parasites, a profile similar to that obtained with GFP-
MPK10-K51A. We observed a higher percentage of cell death of
GFP-MPK10 NM (4165%) compared to UC parasites. This
difference is largely attributed to the over-expression of MPK10,
as there is only a slight yet statistically significant difference
between the percentage of cell death of untransfected parasites and
transgenic parasites expressing the empty vector during axenic
amastigote differentiation (supplementary Figure S7). This finding,
which was not observed in promastigotes, indicates that the over-
expression of MPK10, regardless of its activity, is somewhat
detrimental to axenic amastigotes.
We next compared the phenotype of strains over-expressing
GFP-MPK10 to those over-expressing GFP-MPK10-Y192F, -
T190A or -T190A_Y192F (Figure 4B, lower panels). All mutant
strains showed a 24 hours growth delay, which corresponded to a
higher percentage of cell death compared to that observed for
GFP-MPK10 NM. At 24 h, strains expressing GFP-MPK10-
Y192F and -T190A_Y192F showed a percentage of cell death of
Figure 5. The C-terminal domain negatively regulates MPK10 activity in situ. (A), (D) Proliferation and viability analysis. The analyses
represent the combined results of two triplicates experiments. 26105 promastigotes (A) and 16106 amastigotes (D) were cultured for 8 days and
aliquots were taken every 24 h for analysis. Cell number and percent of cell death were assessed by flow cytometry. The cell lines that were tested are
GFP-MPK10, NM (grey line, grey circles), GFP-MPK10-DC, DC (black line, black squares), GFP-MPK10-DC-K51A, DC-K/A (black line, open triangles), GFP-
MPK10-DC-Y192F, DC-Y/F (black line, black circles). Mean values of the results obtained in two independent experiments in triplicate were plotted,
with standard deviations indicated by the bars. (B) In vitro kinase assay. GFP-MPK10-DC_K51A (DC_K/A) and GFP-MPK10-DC_Y192F (DC_Y/F)
obtained from respective transgenic promastigotes were incubated for 30 min at 37uC and pH 7.5 with 25 mg MBP as substrate. Reaction samples
were separated by SDS-PAGE, gels were stained by Coomassie (Coom.), and signals revealed by auto-radiography (Auto-rad.) using the indicated
exposure time. (C) Western blot analysis. Proteins were purified from promastigotes and analyzed by western blotting using anti-phospho-tyrosine
(a-pTyr) and anti-MPK10 (a-MPK10) antibodies. All blots and auto-radiograms are representative of three independent experiments.
doi:10.1371/journal.ppat.1004347.g005
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5167% and 4866.1%, respectively (Figure 4B, lower panel right),
but recovered thereafter and showed growth characteristics similar
to the GFP-MPK10 NM used as control (Figure 4B, lower panel
left). Parasites expressing GFP-MPK10-T190A showed a more
severe phenotype with 6167.6% of cell death (Figure 4B, lower
panel right), from which they recovered slower than the other
mutants (Figure 4B, lower panel left). This dominant negative
effect, observed during the first 48 h after pH and temperature
shift, corresponds to the period where MPK10 is the most active.
Altogether, these data indicate that MPK10 could be important
only transiently during differentiation. Moreover, these findings
show that not only T190 phosphorylation is essential for the
catalytic activity of MPK10 in promastigotes but also for axenic
amastigote viability. Strikingly, increased cell survival can be
restored in the GFP-MPK10-T190A mutant by Y192F mutation.
We then measured the kinase activity of the purified mutant
proteins from parasites at 48 h of differentiation, when the
percentage of cell death was the highest, and at 96 h after
differentiation, when parasites have recovered. As shown in
Figure 4C, we obtained similar results from amastigotes at 48 h
(left panel) and 96 h (right panel) to those obtained from
promastigotes, i.e. no kinase activity was detected for GFP-
MPK10-K51A, -T190A, -Y192F or -T190A_Y192F. We did not
find a clear correlation between over-expression phenotype and
MPK10 kinase activity, as all mutant kinases were inactive, yet
only the over-expression of GFP-MPK10-T190A was detrimental
for the amastigotes, suggesting that the effect on growth is not
entirely due to whether the protein is active or not. We only
observed this phenotype in axenic amastigotes but never in
promastigotes. This phenomenon may be due to the level of GFP-
MPK10 expression, which was two- to five-fold lower in
promastigotes compared to axenic amastigotes (data not shown).
Thus, the level of transgenic MPK10 NM and MPK10 mutant
protein could be too low to efficiently compete with the
endogenous MPK10 in promastigotes, masking a dominant-
negative effect. Why and how MPK10 levels are regulated in
promastigotes and not in axenic amastigotes remains to be
established. This observation seems independent from the vector,
as expression of other kinases was not regulated the same way
(data not shown). Altogether, these data confirm the essential role
of both residues of the TxY motif for MPK10 activity.
The C-terminal domain negatively regulates MPK10
activity in situ
Our observation that auto-phosphorylation activity of recom-
binant MPK10 is enhanced after removal of the 46 C-terminal
amino acids primed us to investigate the role of this domain in the
regulation of MPK10 NM in its physiological context using our
transgenic system. Compared to GFP-MPK10 NM transgenic
parasites, GFP-MPK10-DC over-expression had neither an effect
on promastigote growth (Figure 5A, left panel) nor cell death
(Figure 5A, right panel). We next measured the kinase activity of
this mutant. As judged by quantification using imageJ, a 3.5 fold
increase in phosphorylation of MBP by GFP-MPK10-DC
compared to that obtained by GFP-MPK10 was observed
(Figure 5B), demonstrating that transgenic GFP-MPK10-DC has
a higher activity than GFP-MPK10. Strikingly, GFP-MPK10-DC
showed a strong increase of MBP phosphorylation but a moderate
increase of auto-phosphorylation, suggesting that part of the
increase in activity could be due to a better affinity for the
substrate rather than enhanced phosphotransferase activity. This
finding supports the hypothesis that the C-terminal domain has an
auto-inhibitory function in situ. Surprisingly, Y192 phosphoryla-
tion was reduced by 80% in GFP-MPK10-DC compared to
GFP-MPK10 NM (Figure 5C). Thus, although only 20% of GFP-
MPK10-DC showed Y192 phosphorylation and thus can be
considered active, the truncated kinase still phosphorylated MBP
3.5 fold more efficiently than GFP-MPK10 NM, suggesting a
dramatic increase in kinase catalytic function after removal of the
C-terminal domain.
We investigated in the following the effect of GFP-MPK10-DC
over-expression on axenic amastigotes. Contrary to promastigotes,
the over-expression of GFP-MPK10-DC caused an important
reduction of cell growth after temperature and pH shift
(Figure 5D, left panel), which resulted from an increase in the
percentage of parasite death during the differentiation process,
reaching 7868.5% at 48 h. In contrast to the over-expression of
the other mutants (Figure 4B), GFP-MPK10-DC transgenic
parasites did not recover and maintained a high level of cell
death. This result indicates that GFP-MPK10-DC is toxic for
axenic amastigotes and as a consequence we were not able to
investigate the kinase activity of GFP-MPK10-DC at this parasite
stage. However, based on the enhanced activity detected in
promastigotes, we hypothesized that the toxicity could be the
consequence of a non-physiologically high level of MPK10 kinase
activity. To test this possibility we generated two double mutants,
GFP-MPK10-DC_K51A and -DC_Y192F that lack activity by
different means. Over-expression of GFP-MPK10-DC_Y192F was
no longer toxic for axenic amastigotes, suggesting that rendering
GFP-MPK10-DC inactive is sufficient to rescue the parasites from
the lethal phenotype as the percentage of cell death was
significantly reduced compared to the active kinase (Figure 5D,
right panel). GFP-MPK10-DC_K51A also showed a reduction in
toxicity but not as complete as GFP-MPK10-DC_Y192F. This
discrepancy was due to a higher percentage of cell death from 48 h
to 144 h, which was not observed with the over-expression of
GFP-MPK10-DC_Y192F. We next investigated whether this
difference between GFP-MPK10-DC_K51A and -DC_Y192F
could be explained by a difference in kinase activity but, as shown
in Figure 5B and expected from the results obtained with the
mutants of full length MPK10, both mutants showed a weak or no
activity towards MBP, respectively. Thus, the different phenotypes
observed with these two mutants are not linked to a difference in
kinase activity. We further showed that in contrast to hyperactive
GFP-MPK10-DC, the level of Y192 phosphorylation of
inactive GFP-MPK10-DC_K51A corresponds to wild-type level
(Figure 5C), thus revealing a negative feedback loop between
MPK10 activity that controls the level of Y192 phosphorylation.
Overall, these findings demonstrate that the toxicity following
over-expression of GFP-MPK10-DC in amastigotes is due to the
high activity of the truncated kinase, which can be compensated
by reduction of tyrosine phosphorylation.
Serine 395 could be implicated in MPK10 regulation
After demonstrating the importance of the C-terminal domain
for auto-inhibition of MPK10 activity and parasite viability, we
investigated the potential mechanisms involved in its regulation.
Several mechanisms have been described to release kinases from
auto-inhibition, including protein phosphorylation [45]. We
performed a qualitative phospho-peptide analysis using L.
donovani axenic amastigote extracts (48 h of axenic differentia-
tion) to test this possibility. Our analysis identified the expected
phospho-peptides encompassing the TxY motif (supplementary
Figure S8A), but revealed a novel phospho-peptide located in the
C-terminal domain of MPK10 showing a single phosphorylation
at residue S395 (supplementary Figure S8B). This serine is
conserved across MPK10 orthologs in trypanosomatids
(Figure 6A, gray arrow), and part of the conserved sequence
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Figure 6. The regulatory Serine 395 residue shows stage-specific phosphorylation. (A) Multiple sequence alignment of MPK10 orthologs
from trypanosomatids generated with Clustal-X and visualized with BioEdit. The phospho-serine residue S395 is marked by the grey arrow. LmjF, L.
major Friedlin; LmxM, L. mexicana MHOM/GT2001/U1103; LinJ, L. infantum JPCM5; LdBPK, L. donovani BPK282A1; LbrM, L. braziliensis MHOM/BR/75/
M2904; LtaP, L. tarentolae Parrot-TarlI; Tb, T. brucei; Tbg, T. brucei gambiense DAL972; TcIL3000, T. congolense IL3000; TcCLB, T. cruzi CL Brener;
TCSYLVIO, T. cruzi Sylvio X10/1; Tc_MARK, T. cruzi marinlellei strain B7; TvY486, T. vivax Y486. Color code: Black, identical residues; Grey, similar
residues; White, no conservation. (B) The level of phosphorylated S395 (pS395) isolated from promastigotes (P) and axenic amastigotes (Ax) was
determined by SRM analysis as described in legend of Figure 3E. (C), (F) Proliferation and viability analysis. The analyses represent the combined
results of two triplicates experiments. 26105 promastigotes (C) and 16106 amastigotes (F) were cultured for 8 days and aliquots were taken every
24 h for analyses. Cell number and percent of cell death were assessed by flow cytometry. The cell lines that were tested are GFP-MPK10 NM (grey
line, grey circles), GFP-MPK10-S395A, S/A (black line, black crosses). Mean values of the results obtained in three independent triplicate experiments
were plotted, with standard deviations indicated by the bars (*: p,0.05; **: p,0.01; ***: p,0.001). (D) In vitro kinase assay. Non-mutated GFP-MPK10
NM and mutated GFP-MPK10-S395A (S/A) obtained from promastigotes (Pro) and axenic amastigotes (Ax. Ama) at 48 h and 96 h during axenic
differentiation were incubated for 30 min at 37uC and pH 7.5 with 25 mg MBP as substrate. Reaction samples were separated by SDS-PAGE, gels were
stained by Coomassie (Coom.), and signals revealed by auto-radiography (Auto-rad.) using the indicated exposure time. The numbers represent the
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motif DHMxRTxSxME (underlined, Figure S3A), which suggests
an important role for MPK10 function. If this serine were
implicated in the regulation of MPK10 auto-inhibition, we would
expect its phosphorylation to be stage regulated. To test this
hypothesis we took advantage of the previously described
quantitative phospho-peptide analysis. SRM analysis confirmed
the presence of phosphorylated S395, which was mostly identified
in promastigotes. Besides T190 of the activation loop this is the
second stage-specifically regulated residue in MPK10 and thus
may be crucial to control kinase activity (Figure 6B). As this
promastigote-specific phosphorylation occurs when MPK10 is
least active, dephosphorylation of S395 could be important to
release MPK10 from the auto-inhibition.
We next investigated this possibility and studied the role of this
residue in MPK10 regulation by generating transgenic parasites
over-expressing GFP-MPK10-S395A. No difference was observed
between GFP-MPK10 NM and -S395A with respect to promas-
tigote growth (Figure 6C, left panel) or percentage of cell death
(Figure 6C, right panel). Comparison of the kinase activities of
GFP-MPK10 NM and -S395A purified from promastigotes did
not reveal any difference based on quantification of the signals by
a scintillation counter as detailed in Figure 3A (Figure 6D). We
next compared the kinase activity of GFP-MPK10 NM and
-S395A purified from parasites at different time points during
axenic amastigote differentiation (Figure 6D). At 48 h, GFP-
MPK10 NM phosphorylated MBP more efficiently than GFP-
MPK10-S395A (100% and 54% respectively), whereas the activity
of the mutant protein was slightly stronger than that of GFP-
MPK10 NM at 96 h (127% and 100% respectively). These
findings provide evidence for a delay in GFP-MPK10-S395A
activation, supporting a role of this residue in proper kinase
regulation.
The mean values with standard deviation of three independent
experiments assessing activity for GFP-MPK10 NM and -S395A
of parasites at 48 h and 96 h during axenic amastigote differen-
tiation is shown in Figure 6E. Statistically significant differences
were observed at 48 h with a reduction by twofold of GFP-
MPK10-S395A activity (p-value,0.001), and at 96 h where on
the contrary GFP-MPK10-S395A activity is increased by 75% (p-
value,0.05). No significant difference was observed in promasti-
gotes (p-value of 0.06). These data strongly suggest that in axenic
amastigote, GFP-MPK10-S395A is differentially regulated com-
pared to GFP-MPK10 NM, which could cause the observed effect
on parasite viability. Parasites expressing GFP-MPK10-S395A
presented a delay of 24 h in cell growth compared to GFP-
MPK10 NM but thereafter resumed growth with kinetics slightly
slower than that of parasites overexpressing GFP-MPK10 NM
(Figure 6F, right panel). This delay is caused by a significantly
higher percentage of cell death (69616%, p-value,0.01) observed
for parasites expressing GFP-MPK10-S395A at 48 h of axenic
amastigote differentiation compared to GFP-MPK10 NM
(44612%, Figure 6F, right panel). In conclusion, our findings
demonstrate the importance of S395 residue for axenic amastigote
survival. The fact that the GFP-MPK10-S395A phenotype
resembles that obtained with the over-expression of GFP-
MPK10-T190A attributes similar importance for kinase regulation
to S395 in the C-terminal domain as to T190 in the activation
loop.
Discussion
While the biological processes underlying Leishmania stage
differentiation are poorly understood, the regulation of parasite
development by environmental cues is firmly established. In
eukaryotes, the MAPK pathway transmits environmental signals
to trigger a wide range of cellular response. Thus studying the
Leishmania MAPK pathway can provide new insight into
molecular mechanisms underlying parasite differentiation and
parasite-specific kinase biology. Here we uncover novel mecha-
nisms regulating the Leishmania MAP kinase homolog MPK10 by
utilizing two complementary approaches to study MPK10
regulation. First, recombinant expression and purification of
MPK10 enabled us to identify a potential auto-inhibitory domain
at the C-terminus of the protein. Second, transgenic expression
and purification of MPK10 kinase allowed us (i) to validate
MPK10 auto-inhibition in situ, (ii) to demonstrate the importance
of the C-terminal domain for axenic amastigote survival, and (iii)
to identify T190 and S395 as key regulatory residues. We propose
that auto-inhibition of active MPK10 provides a fast signaling
switch likely involved in environmentally induced pro- to axenic
amastigote conversion and stage-specific regulation of MPK10
activity.
MPK10 is an atypical eukaryotic MAPK
MAPKs are proline-directed serine/threonine kinases that
phosphorylate substrates containing proline in the P+1 site [46].
Classically, MAPKs are inactive enzymes that are solely activated
by M2Ks, which phosphorylate both the threonine and the
tyrosine of the TxY motif present in the activation loop [9,46].
This phosphorylation allows conformational changes that lead to
the alignment of the R and C spines required for the activation of
the kinase [29,35,36]. Moreover, the phosphorylation of the
tyrosine residue of the TxY motif is important to permit the
formation of the proline-directed P+1 specificity site required for
substrate recognition and restriction of specificity [46]. The
threonine residue possesses a structural role by stabilizing MAPK
conformation and improving the geometry of the active site
[46,47]. MPK10 retains certain characteristics of classical MAPKs
such as the conserved motif typical of MAPKs, TxYxxxRxYRxPE,
including the TxY motif and the (P+1)-specificity pocket [16]. We
demonstrated the importance of the T190 residue for the catalytic
activity of MPK10, as alteration of this site abrogates phospho-
transfer and severely reduces axenic amastigote survival. We also
showed the essential role of the Y192 residue for MPK10 activity
although its mutation does not have an impact on axenic
amastigote survival unlike mutation of T190.
Aside these conserved MAPK features, MPK10 regulation
presents many non-classical characteristics. We have previously
shown that based on its structural conformation, MPK10 appears
to be in an active conformation, without the need for dual-
phosphorylation of the TxY motif, as the replacement of the DFG
motif by a DFN motif results in the alignment of the R and C
spines, similar to eukaryotic MAPKs after phosphorylation of the
TxY motif by M2Ks [29]. Our study supports these findings
revealing alternative modes of regulation of this intrinsic MPK10
activation state. We first showed that phosphorylation of Y192 is
largely dissociated from MPK10 activity as its phosphorylation
level of radioactive counts as determined by a scintillation counter. Signals were normalized to the counts obtained with GFP-MPK10 NM on MBP and
set at 100%. (E) Histogram plot of the radioactive counts obtained from MBP after kinase assay normalized to the values obtained with GFP-MPK10
NM on MBP and set at 100%. Histograms represent mean values and the standard deviation is denoted by the error bars. Results are representative of
three independent experiments. The asterisks represent statistical significance, with *: p,0.05; **: p,0.01; ***: p,0.001.
doi:10.1371/journal.ppat.1004347.g006
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state does not show any significant stage-specific change, even
though the activity of MPK10 increases by about twofold between
log phase promastigotes and axenic amastigotes at 48 h after
initiation of differentiation. In classical MAPKs, kinase activity
correlates with phosphorylation of both the threonine and the
tyrosine residues of the TxY motif, which is tightly regulated by
environmentally induced upstream M3Ks and M2Ks [9]. By
contrast, our data suggest that Leishmania MPK10 is mostly
constitutively phosphorylated on Y192 in promastigotes and
during amastigote development and proliferation. Consequently,
this residue seems not to be implicated in regulating the observed
stage-specific activation of MPK10. These findings were con-
firmed by proteomics identification of a mono-phosphorylated
T190-H-pY192 activation loop in both pro- and axenic amasti-
gotes, whereas dual pT190-H-pY192 phosphorylation of the
activation loop was mainly identified in axenic amastigotes, where
MPK10 is most active. However, we observed a decrease in Y192
phosphorylation in axenic amastigotes at stationary phase, which
correlated with a decrease in MPK10 activity, suggesting that
inactivation of MPK10 at this stage requires Y192 dephosphor-
ylation.
Altogether, these findings indicate that the two residues of the
TxY motif are differentially regulated, raising the question on how
MPK10 is phosphorylated by M2Ks. There are at least five
possibilities: (i) Y192 could be auto-phosphorylated in cis, a
possibility that we rule out since kinase dead MPK10-K51A still
shows phosphorylation on this residue. (ii) Classically, the
phosphorylation of the TxY motif by M2Ks is sequential, initiating
with the tyrosine residue [48]. M2Ks could constitutively
phosphorylate the tyrosine residue of MPK10, but require
additional signals or interactions to complete phosphorylation of
the adjacent threonine residue. (iii) Each regulatory residue could
be phosphorylated independently by two different M2Ks as it was
demonstrated for human JNK kinase, whose threonine of the TxY
motif is preferentially phosphorylated by MKK7, whereas its
tyrosine is preferentially phosphorylated by MKK4 [9]. (iv)
Without activation of the MAPK cascade, only Y192 could be
accessible for phosphorylation, whereas access to T190 could be
blocked by the C-terminal domain. (v) Both sites could
be phosphorylated by the same M2K but only T190 would be
constantly dephosphorylated until the MAPK pathway is fully
activated. Three types of phosphatases target MAPKs, the dual-
specificity phosphatases also called the MAP kinase phosphatases
(MKPs), the tyrosine phosphatases such as PTP-SL and STEP,
and finally the serine/threonine phosphatase such as PP2A [49].
PP2A could likely be responsible for this dephosphorylation; a
possibility supported by recent findings that T. cruzi PP2A blocks
axenic amastigote differentiation [50].
Dissociation of Y192 phosphorylation from stage-specific induc-
tion of MPK10 activation during amastigote differentiation raises
the question of its importance forMPK10 function. We showed that
similar to mammalian MAPKs, the Y192 residue is essential for
MPK10 enzymatic activity. However, the dominant negative effect
generated by overexpression of MPK10-T190A on axenic amasti-
gote growth and viability was more detrimental than the one
observed by overexpression of MPK10-Y192F, suggesting a more
important role for the T190 residue for MPK10 activity. We can
only speculate on the role of the largely constitutive phosphorylation
of the Y192 residue. As described in the literature, phosphorylation
of the tyrosine of the TxY motif is important to form the proline-
directed (P+1)-specificity pocket [46,49]. Consequently, maintain-
ing Y192 mostly phosphorylated could allow a constant and
dynamic interaction of MPK10 with its substrates allowing for faster
phosphorylation once the pathway is activated.
A second striking feature of the regulation of MPK10 is
represented by its C-terminal domain. Whether we used the
recombinant or the transgenic protein, removal of this domain
resulted in a significant increase in kinase activity. While this
increase translates mainly into higher auto-phosphorylation levels
for the recombinant kinase, we observed a dramatic increase in
substrate phosphorylation for the transgenic kinase. One main
difference between the two kinases is the absence of Y192
phosphorylation of the recombinant protein, which could explain
the inability of recombinant kinase to efficiently transfer phosphate
onto the substrate (Figure S5). Thus, our findings firmly establish
regulation of MPK10 through auto-inhibition. This is a common
feature in the regulation of kinase activities, and has been
described for example for Twitchin kinase or CaMKI (Ca2+/
calmodulin-dependent kinase I) but is a rare feature for MAPKs
[48]. Although five human MAPKs have a long C-terminal
domain (ERK3, ERK4, ERK5, ERK7 and ERK8), only that of
ERK5 has an auto-inhibitory function [9]. The authors have
shown that deletion of the last 100 amino acids of ERK5 leads to
an increase of its kinase activity and they postulated that the
deletion of the C-terminal domain could facilitate its activation by
the upstream kinase [51]. Evidence for a different auto-regulatory
mechanism of MPK10 arises from our analysis using transgenic
parasites expressing the hyper-active MPK10 C-terminal deletion
mutant: the strongly reduced phosphorylation levels of the
regulatory Y residue in this mutant despite its significantly
increased phosphotransferase activity demonstrates that the pool
of active MPK10 is reduced, while the activity of each single active
kinase protein is dramatically increased. Thus the deletion of the
C-terminal domain increases the basal activity of the truncated
kinase rather than allowing better access for the M2K. How the C-
terminal domain regulates MPK10 activity is still elusive since no
conserved pattern or domains such as SH2 or SH3 have been
identified. One possible explanation could be that the C-terminal
domain masks the active site acting as a pseudosubstrate such as
described for Twitchin kinase [52]. It is interesting to note that in
T. brucei, a hybrid kinase between a CDK (Cyclin dependent
kinase) and a MAPK termed TbECK1 is also auto-inhibited by its
C-terminal domain [32]. Procyclic parasites expressing the
truncated protein showed growth defects and the parasites
presented aberrant karyotypes. The expression of truncated
TbECK1 was toxic to the bloodstream form, which is reminiscent
to the toxic effect of MPK10-DC in axenic amastigotes.
Our data show that activating MPK10 via T190 is important
for axenic amastigote survival, especially during the first 48 h after
induction of axenic amastigote differentiation by temperature and
pH shift. However, inhibition of MPK10 activity is equally
essential as absence of auto-inhibition caused massive cell death in
axenic amastigotes expressing MPK10-DC. These results therefore
demonstrate the transient requirement for MPK10 during axenic
amastigote differentiation and reveal a new mechanism to regulate
MAPK activity by auto-inhibition, which is crucial for amastigote
viability.
Finally, we identified a highly conserved, trypanosomatid-
specific serine at position 395 inside the MPK10 C-terminal
domain as a novel, stage-specific regulatory residue that is mainly
phosphorylated in promastigotes and whose mutation causes an
important dominant negative effect on axenic amastigote survival.
Because kinases can be released from auto-inhibition by
phosphorylation or dephosphorylation [45], we hypothesized that
S395 could be implicated in the regulation of the auto-inhibition of
MPK10 by its C-terminal domain. We did not confirm this
hypothesis but we have two pieces of evidence suggesting that this
residue could have an important role in the regulation of MPK10
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activity. First, we showed that S395 is conserved in all
trypanosomatids and is part of a sequence motif inside the C-
terminal domain, which is also conserved in all trypanosomatids.
Second, we clearly established the importance of the phosphor-
ylation of S395 for axenic amastigote survival, which is as
important as the regulation of T190, and partially mimics the
viability defect caused by MPK10-DC. The function of this residue
is still elusive and may be studied in the future by using an anti-
phospho-S395 specific antibody to investigate the link between the
phosphorylation kinetics of this residue and MPK10 activity, and
address the question whether the release from auto-inhibition is
regulated by environmental signals or whether it is alleviated
before signal sensing, leaving the kinase in a semi-activated state,
relying only on T190 phosphorylation for activation.
MPK10 activity is regulated by a feedback loop
Because MPK10 shows a transient peak of activity during the
first 48 h of axenic amastigote differentiation, its activity seems to
be tightly regulated. The decrease in MPK10 activity after 48 h of
induction of axenic amastigote differentiation is concomitant with
the decrease of Y192 phosphorylation, suggesting that dephos-
phorylation of Y192 and probably T190 are required for MPK10
inactivation. We have evidence suggesting that MPK10 could
directly or indirectly regulate its activity through the phosphor-
ylation or the dephosphorylation of its TxY motif. Indeed, we have
shown that to reduce toxicity caused by the over-expression of the
hyperactive MPK10-DC, its level of Y192 phosphorylation was
decreased. The level of pY192 was restored to wild-type level only
after rendering the truncated kinase inactive, suggesting the
existence of a feedback loop, where MPK10 could either inactivate
the M2K that phosphorylates Y192 or activate the phosphatase
that dephosphorylates this residue. This kind of feedback
regulation between MAPKs and M2Ks or MKPs has not been
extensively studied, as only three types of feedback loop have been
described that are linked to regulation of MKPs, involving (i)
rescue of MKP from degradation through phosphorylation by
MAPK [53], (ii) activation of MKP by MAPK binding [54], and
(iii) induction of MKP transcription by activated MAPK [55,56], a
possibility that can likely be discarded as transcription is
constitutive in Leishmania [57]. In addition, Mody et al. have
reported the phosphorylation of MKK5 by ERK5, revealing the
existence of a potential feedback loop between a MAPK and its
upstream activating kinase [58]. Future identification of the M2K
and MKP that regulate the phosphorylation dynamics of the TxY
motif of MPK10 will provide more insight into the mechanism
controlling this feedback loop.
In conclusion, our transgenic study identifies novel mechanisms
of MPK10 regulation that are unusual for MAPKs and document
once more the stunning capacity of Leishmania to adapt highly
conserved signaling proteins to its parasitic life style. Our data
propose a model in which MPK10 is not inactivated but partially
active in promastigotes as judged by tyrosine phosphorylation and
structural conformation (Figure 7). At this stage the kinase is kept
in a standby configuration by auto-inhibition. During the first 48 h
Figure 7. Model of MPK10 regulation based on our data. We propose a model in which MPK10 is not inactivated but partially active in
promastigotes as judged by tyrosine phosphorylation and structural conformation. At this stage the kinase is kept in a standby configuration by auto-
inhibition. During the first 48 h of axenic amastigote differentiation, MPK10 is released from auto-inhibition, which correlates with T190
phosphorylation and S395 dephosphorylation. This activity seems to be controlled by a feedback loop where MPK10 regulates its own tyrosine
phosphorylation levels. Thereafter, MPK10 activity is decreased likely due to dephosphorylation of the TxY motif and phosphorylation of S395.
doi:10.1371/journal.ppat.1004347.g007
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of axenic amastigote differentiation, MPK10 is released from auto-
inhibition, which correlates with T190 phosphorylation and S395
dephosphorylation. This activity seems to be controlled by a
feedback loop where MPK10 regulates its own tyrosine phos-
phorylation levels. Thereafter, MPK10 activity is decreased likely
due to dephosphorylation of the TxY motif and phosphorylation
of S395. These regulatory residues may fine tune MPK10
regulation according to environmental signals and differentiation
state through activating and inhibitory mechanisms. Future studies
combining null mutant analysis and complementation assays for a
detailed structure-function analysis of these residues and the auto-
inhibitory C-terminal domain will uncover the contribution of
these sequence elements in regulating MPK10 functions relevant
for parasite differentiation and infectivity.
Materials and Methods
Parasite cell culture and differentiation
Leishmania donovani strain 1S2D (MHOM/SD/62/1S-
CL2D), clone LdB was cultured and axenic amastigotes were
differentiated as previously described [4] [59] [60]. Briefly, 106
logarithmic promastigotes per mL were grown at 26uC in M199
media (supplemented with 10% heat-inactivated FCS, 25 mM
HEPES pH 6.9, 4.2 mM NaHCO3 7.5%, 2 mM glutamine,
8 mM 6-biopterin, 16RPMI 1640 vitamin mix, 10 mg/mL folic
acid, 100 mM adenine, 30 mM hemin, 100 U/mL of Penicillin/
Streptomycin (Pen/Step)) and differentiated in axenic amastigotes
by incubation at 37uC and 5% CO2 with RPMI media
(supplemented with 20% of heat-inactivated FCS, 28 mM MES,
2 mM glutamine, 16 RPMI 1640 amino acid mix, 10 mM folic
acid, 100 mM adenine, 100 U/mL of Pen/Step). Parasites were
harvested at different time points between 12 h to 144 h after
induction of axenic amastigote differentiation. For kinetic analysis,
one flask (Corning) containing 200 mL of culture medium was
used for each time point to avoid internal variations.
Leishmania mexicana MNYC/BZ/62/M379 promastigotes and
axenic amastigotes were grown as described previously [61].
Cultures were incubated at 27uC until late-log phase (4–56107
parasites/ml), and either harvested or differentiated into amasti-
gotes by inoculation in Schneider’s Drosophila medium (PAN
Biotech, Aidenbach, Germany) supplemented with 20% heat-
inactivated FCS (PAN Biotech), 2 mM L-glutamine, 100 U/ml
Pen/Strep, and 20 mM 2-morpholinoethanesulfonic acid mono-
hydrate [MES] (Serva, Heidelberg, Germany) for a final pH of
5.5. Cultures were incubated at 34uC, 5% CO2, for 72 h. Parasites
were harvested by centrifugation at 2,0006g at 4uC, and washed
consecutively in ice-cold HEPES and ice-cold HEPES with
protease and phosphatase inhibitors (1 mM Na-orthovanadate,
0.1 mM okadaic acid, 10 mM NaF, 10 mM o-phenanthroline,
EDTA-free protease inhibitors (Roche)). Parasite pellets were
snap-frozen in liquid nitrogen and stored at 280uC.
Plasmids
pXG-GFPK10. For transgenic expression of GFP-MPK10
fusion protein, the gene encoding the L. major MAPK homologue
LmaMPK10 (accession number CAJ02415) was PCR amplified
from 50 ng of genomic DNA of L. major FVI using primers 59-
ACCAGATCTCCACCATGCAGGCCAAGGGC-39 (forward)
and 59-GCGAGATCTTCACGACGGGGCCGGCGC-39 (re-
verse) and cloned into pGEM-T (Promega) to obtain pGEMT-
MPK10. This plasmid was subsequently digested by BglII and
subcloned into pXG-GFP+2 to generate pXG-GFP-MPK10 (kindly
provided by S. Beverley, Washington University Medical School,
St. Louis, MO, USA). The various MPK10 mutants described in
the results section were obtained by site direct mutagenesis of
pGEMT-MPK10 using the QuickChange II XL Site-Directed
Mutagenesis kit (Stratagene) prior to subcloning into pXG-GFP2+.
MPK10-DC was PCR amplified with primers 59-ACCAGATCTC-
CACCATGCAGGCCAAGGGC-39 (forward) and 59-GCGA-
GATCTTCAGTCGTTGAAGCGCTCC-39 (reverse) containing
a stop codon to generate a protein deleted for the last 46 amino-
acids (138 nucleotides) from the C-terminal end of LmaMPK10,
and was cloned into pXG-GFP2+ as described above to generate
the pXG-GFP-MPK10-DC construct. All constructs were validated
by sequence analysis.
pQE80-His6-MPK10. For recombinant protein production,
the sequences encoding for LmaMPK10 and LmaMPK10-DC
were amplified by PCR and subcloned into plasmid pQE80
(Qiagen, Venlo, the Netherlands), previously modified to carry a
Tobacco Etch Virus (TEV) protease cleavage site for removal of
the N-terminal His-tag as previously described [29]. The same
strategy as described above was applied to obtain mutated kinase
constructs. All constructs were validated by sequence analysis.
pGEX-GST-Strep3-MPK10. An alternative expression con-
struct for recombinant MPK10 production was created by PCR
amplification of LmaMPK10 with primers 59-TTCGAAA-
AAGGTGGAATGCAGGCCAAGGGCG-39 (forward) and 59-
CCCGGGTCACGACGGGGCCGGCG-39 (reverse), and the
fragment was cloned into pGEM-T vector to obtain pGEM-
MPK10-NcoI-BstBI. Primers 59-CATGGATCCTTATGTG-
GAGCCACCCGCAGTTCGAGAAAGGTGGAGGTTCCTG-
GAGCCACCCGCAGTT-39 and 59-CGAACTGCGGGTG-
GCTCCAGGAACCTCCACCTTTCTCGAACTGCGGGTGG-
CTCCACATAAGGATC-39 were annealed and subsequently
phosphorylated to generate a double stranded oligonucleotide
containing the Strep3 sequence with 59 overhangs. This fragment
was cloned into pGEM-MPK10, digested by NcoI/BstBI, to
generate the pGEM-Strep3-MPK10 plasmid. pGEM-Strep3-
MPK10 was digested by BamHI/NotI and cloned into pGEX-
5X-1 (Abbgene) to generate pGEX-GST-Strep3-MPK10. The
same strategy as described above was applied to obtain mutated
kinase constructs. All constructs were validated by restriction
enzyme digestion and sequencing.
Parasite transfection
Episomal tranfectants were generated by electroporation of
56107 L. donovani LdB promastigotes from logarithmic culture
with 20 mg of plasmid [62]. Transfected cells were selected in
liquid media containing 20 mg/ml geneticin (Invitrogen) and
resistant parasites were expanded in liquid culture at drug
concentrations up of to 100 mg/ml of geneticin. Parasites were
then frozen one passage after selection and all experiments were
performed with parasites issued from the same electroporation. To
avoid any potential bias due to adaptation or compensatory
responses, parasites were used for all the experiments at passage 2
after selection. Pools of transfectants were used to avoid clonal
variation that can bias transgenic studies.
Cell death analysis
Cultured parasites were incubated for 15 min with 10 mg/ml
propidium iodide (Sigma-Aldrich) and diluted in PBS (Gibco).
Cells were analyzed with a FACSCalibur flow cytometer (Beck-
man Coulter) to determine the incorporation of propidium iodide
(excitation wave length lex=488 nm; emission wave length
lem=617 nm). The percentages of cell death and cell growth
were calculated using FlowJo (v7.6) software (Tree Star, Inc., San
Carlos, CA).
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Protein extraction and purification
109 parasites were washed with ice cold RPMI and lysed in 1 ml
lysis buffer containing 150 mM NaCl, 1% Triton X-100, 50 mM
Tris HCl pH 8 and inhibitor cocktails for proteases (Complete
Mini EDTA-free tablets, Roche Applied Science, IN) and
phosphatases (Phosphatase Inhibitor Cocktails I and II, Sigma–
Aldrich, MO). Clear lysates were obtained after sonication and
centrifugation at 12 0006 g for 10 min and stored at 280uC.
Purified GFP-MPK10 wild-type and mutant proteins were
isolated from crude cell extracts of respective transgenic parasites
using the mMACS Epitope Tag Protein Isolation Kit, according to
the manufacturer’s specifications (Miltenyi Biotec Inc., CA).
Briefly, equal amounts of total proteins were incubated with
50 ml of magnetic bead-conjugated mouse monoclonal anti-GFP
antibody for 1 hour at 4uC, immuno-complexes were immobilized
on the mMACS separator, washed four times with 150 mM NaCl,
1% Igepal CA-630 (formerly NP-40), 0.5% sodium deoxycholate,
0.1% SDS, 50 mM Tris HCl (pH 8.0), and once with 20 mM Tris
HCl (pH 7.5). Bound GFP-MPK10 protein was eluted in 75 ml
PBS after removing the columns from the magnetic field.
SDS-PAGE and western blot analysis
Purified proteins were separated by SDS–PAGE (NuPAGE gel
4–12% Bis-Tris, Invitrogen) and visualized either by Coomassie
staining or SYPRO Ruby Protein Gel Stain (Invitrogen) using a
Typhoon 9400 scanner (Amersham Biosciences) with
lex=457 nm and lem=610 nm. Alternatively, proteins were
separated by SDS–PAGE on NuPAGE 4–12% Bis-Tris gels
(Invitrogen) and blotted onto polyvinylidene difluoride (PVDF)
membranes (Pierce). Proteins were revealed using the following
antibodies at the indicated dilutions: i) polyclonal anti-MPK10
antibody, generated by rabbit immunization using recombinant
MPK10 protein produced in E. coli transformed with pGEX-
Strep3-MPK10 plasmid (Eurogentec), 1:10,000; ii) anti-phospho-
tyrosine antibody 4G10 Platinum from Millipore, 1:1,000; and iii)
secondary goat anti-rabbit-HRP and anti-mouse-HRP antibodies
from Thermo Scientific, 1:20,000. The visualization was per-
formed on X-ray film (Roche) at various exposure times.
Recombinant expression and purification of MPK10
E. coli BL21 Rosetta (VWR) transformed with pQE80-His6-
MPK10 or pGEX-GST-Strep3-MPK10 were grown at 37uC and
induced with IPTG (0.2 mM final) overnight at RT. Cells were
harvested by centrifugation at 15,0006 g for 10 min at 4uC.
For the purification of GST-Strep3-MPK10, bacteria were
resuspended in a pre-chilled buffer containing 25 mM Tris-HCl
pH 8, 150 mM NaCl, 1 mM DTT, 10 mg/mL apoprotein, 1 mM
leupeptin, 1 mM pepstatin, 1 mM PMSF. Samples were sonicated
(Bioruptor system, Diagenode) for 2 min at 20 V setting on ice
(10 s on/10 s off cycle). After addition of 500 mg/mL of lysozyme
and 500 U of benzonase, lysates were incubated on ice for 30 min
with 140 mM EDTA, 0.0035% Triton-X100 and centrifuged at
15,0006 g for 30 min at 4uC. The supernatant was immediately
subjected to GST affinity chromatography (GSTrap, GE Health-
care Life Sciences, Waukesha, WI, USA). GST-tagged proteins
were washed with a buffer containing 50 mM Tris pH 8, 100 mM
NaCl, 1 mM DTT and eluted with the same buffer supplemented
with 30 mM L-glutathione. Appropriate fractions were pooled and
the GST-tag was cleaved by incubation of the fractions with 5 mg/
mL Xa factor in presence of 1 mM CaCl2. The reaction was
stopped by adding 5 mg/mL of Glutamyl-glycyl-arginine chlor-
omethyl ketone GGACK (Calbiochem). A second purification step
was performed using a StrepTrap column (Strep-tactin, GE
Healthcare Life Sciences, Waukesha, WI, USA). Elution was
performed with E Strep buffer (100 mM Tris-HCl pH 8, 150 mM
NaCl, 1 mM EDTA and 2.5 mM Desthiobiotin) and appropriate
fractions were collected, and stored at 4uC until used.
For His6-MPK10 purification, the bacterial pellet was resus-
pended in PBS containing 60 mM b-glycerophosphate, 1 mM
sodium vanadate, 1 mM sodium fluoride, 1 mM disodium
phenylphosphate, 150 mM sodium chloride, 10 mM imidazole
supplemented with protease inhibitor cocktail (Complete EDTA
free tablets, Roche Applied Science). The sample was sonicated for
2 min at 20 V setting on ice (10 s on/10 s off cycle). Triton X-100
(0.1% final) was added, the sample was incubated for 30 min at
4uC (shaking) and centrifuged at 15,0006 g for 30 min at 4uC.
The supernatant was purified on Co-NTA agarose (Pierce). The
beads were washed with PBS containing 60 mM b-glycerophos-
phate, 1 mM sodium vanadate, 1 mM sodium fluoride, 1 mM
disodium phenylphosphate, 300 mM sodium chloride, 30 mM
imidazole, 1% Triton X-100 at pH 7.5. Elution was performed
with 300 mM imidazole in elution buffer pH 7.5 (PBS containing
60 mM b-glycerophosphate, 1 mM sodium vanadate, 1 mM
sodium fluoride, 1 mM disodium phenylphosphate). The eluate
was supplemented with 15% glycerol and stored at 280uC.
Kinase assay
Ten percent of the GFP-MPK10 purified protein was incubated
on a shaker for 30 min at 37uC with 25 mg myelin basic protein
(MBP) substrate, 200 mM of ATP, 50 mM of MOPS pH 7.5,
100 mM NaCl, 10 mM MgCl2 and 1 mCi [c-
32P] adenosine-
triphosphate (ATP) (3000 Ci/mmol) in final volume of 20 ml. The
phosphotransferase reaction was then stopped by adding Laemmli
loading buffer. Reaction mixtures were separated by SDS–PAGE,
which was stained by Commassie and dried. 32P incorporation was
monitored by exposing the dried gel on an X-ray sensitive film
(Roche) at 280uC. After exposure, the bands corresponding to
MPK10 or MBP were excised from dried gels and radioactivity
was quantified by a scintillation counter.
Recombinant His6-MPK10 and respective mutants were
assayed with 36 mg dephosphorylated casein, 12 mg histone H1,
9 mg of Ets1 or 9 mg MBP as substrates in a Tris buffer at pH 7.5
(50 mM Tris-Cl pH 7.5, 10 mM MnCl2 and 100 mM NaCl) in
20 ml final volume and in the presence of 15 mM [c-33P]-ATP.
After 30 min incubation at 37uC, the reaction was stopped by
adding an equal volume of 26electrophoresis loading buffer to the
20 ml reaction mix. Incorporated 33P was monitored by auto-
radiography.
Partial tryptic digestion of recombinant MPK10
50 mg of Strep3-MPK10 were digested with 0.25 mg trypsin at
RT. Aliquots were taken at 0, 2.5, 5, 15, 30, 60, and 150 min and
the reaction was stopped by adding Laemmli loading buffer. The
polypeptides were then separated by SDS-PAGE, transferred to
PVDF membrane, stained with amidoblack, and N-terminal
sequencing was performed. For the mass determination of
cleavage products, pH of the cleavage reaction was lowered to
5.0 and mass determination was performed by SELDI-TOF
analysis after immobilizing the samples on a H4 ProteinChip
Array (C16 reversed phase surface).
Qualitative phosphopeptides determination
A Leishmania amastigote cell pellet was submitted for qualita-
tive phosphoproteomic analysis using titanium dioxide phospho-
peptide enrichment followed by an iTRAQ labeling experiment
for analysis of phosphopeptides by LC-MS/MS. Briefly, 400 mg of
Leishmania proteins were reduced with DTT and the free
cysteines were alkylated with iodoacetamide for 30 min at 37uC
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in darkness. Proteins were then digested overnight at 37uC using
Porcine trypsin (sample:enzyme ratio of 50:1). Following the
digestion, the peptides were acidified, concentrated and de-salted
using a Waters HLB Oasis SPE cartridge. The peptides were then
enriched for phosphopepitdes using a TiO2 affinity column and
splited into two 100 mL aliquots. Each aliquot was then reduced
and alkylated with MMTS followed by iTRAQ labeling (114,
116). The 116 labeled sample was then treated with FastAPalka-
line phosphatase before the samples were combined, fractionated
by SCX chromatography and analyzed by ESI-Q-TOF MS/MS.
Sample were then analyzed by reversed phase nanoflow (300 nL/
min) HPLC with nano-electrospray ionization using a quadrupole
time-of-flight mass spectrometer (QSTAR Pulsar I, Applied
Biosystems) operated in positive ion mode and a 2 hour gradient.
Quantitative phosphopeptide identification and
quantification
16107 parasites were lysed in a solution of 7 M urea, 2 M
thiourea, 40 mM Tris, 1% n-octyl-b-D-glycopyranoside, 1 mM
MgCl2, 1 mM o-phenanthroline, 300 U benzonase, 1 mM Na-
pervanadate (Na-orthovanadate activated in 18% H2O2), EDTA-
free protease inhibitors (Roche) and phosphatase inhibitor
cocktails (P2850 and P5726 from Sigma), and sonicated for
3615 s on ice. Lysates were incubated at 280uC for 30 min prior
to reduction (DTT, 20 mM, incubation at room temperature for
60 min) and alkylation (iodoacetamide, 40 mM, incubation at
room temperature in the dark for 45 min). Proteins were
precipitated in 8 fold excess of ice-cold acetone-ethanol (1:1, v/
v) by overnight incubation at 220uC. Proteins were reconstituted
in 6 M urea/2 M thiourea and diluted in 50 mM NH4HCO3 for
digestion with trypsin at a 75:1 substrate-enzyme ratio over night.
For selected reaction monitoring (SRM) analyses, 36330 mg
digested protein from whole cell lysates of promastigotes, axenic
amastigotes were subjected to TiO2 enrichment as described in
Rosenqvist et al. [40]. The TiO2 eluates were pooled prior to
SRM analysis. The discovery analyses were conducted in
triplicates for each of the sample types using LTQ Orbitrap XL
mass spectrometers (Thermo Fisher Scientific, Bremen, Germany).
The discovery data were processed with DTASuperCharge
(Mortensen, P. DTASuperCharge, an MSQuant application.
http://msquant.alwaysdata.net/msq/) and searched against a
customized L. mexicana 6-frame translation library as well as a
predicted protein list (GeneDB http://www.genedb.org) using an
in-house Mascot server (version 2.2.06, Matrix Science, London,
UK). For SRM analyses, the discovery data were processed in
ProteomeDiscoverer, and the MPK10 phosphopeptides identified
were imported into Pinpoint, version 1.0.0 (Thermo Scientific).
Bioinformatics approaches
Leishmania spp and Trypanosoma spp MPK10 gene and protein
sequences were retrieved from the web databases GeneDB
(http///www.genedb.org) and TriTrypDB (http://tritrypdb.org/
tritrypdb/) [63]. Homology searches were carried out using
BLAST Program with the default BLOSUM-62 substitution
matrix [64], and pattern recognition analysis using the program
PRATT v2.1 [65]. Multiple sequence alignments were performed
using built-in algorithm ClustalXv2. Additional sequence analyses
were carried out using the BioEdit Program suite (Tom Hall,
North Carolina State University). Statistical analysis and data
plotting were performed using Rstudio software (http://www.
rstudio.org/) and R language (R Development Core Team (2005).
R: A language and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria. ISBN 3-
900051-07-0, URL: http://www.R-project.org). Statistical analy-
ses were performed using the t-test on mean values when samples
followed a Normal distribution, otherwise the Mann-Whitney
Rank Sum Test was used. Differences were considered significant
when p value,0.05.
Supporting Information
Figure S1 A) Multiple sequence alignment of MPK10 orthologs
from Leishmania generated with Clustal-X and visualized with
BioEdit. Color code: black, identical residues; grey, similar
residues; white, no conservation. B) Table of percent of protein
sequence identity of MPK10 from L. donovani compared to other
Leishmania species. LmjF, L. major Friedlin; LmxM, L. mexicana
MHOM/GT2001/U1103; LinJ, L. infantum JPCM5; LdBPK, L.
donovani BPK282A1; LbrM, L. braziliensis MHOM/BR/75/
M2904; LtaP, L. tarentolae Parrot-TarlI.
(TIF)
Figure S2 Effect of pH variation on the activity of recombinant
MPK10. Non-mutated GST-Strep-MPK10 NM and kinase dead
mutant K/A were incubated with casein for 30 min at pH 5.5,
6.5, 7.5 and 8.5 at 37uC. Recombinant human MEK1 was used as
positive control with MBP as substrate at pH 7.5. MW, Molecular
Weight.
(TIF)
Figure S3 A) Multiple sequence alignment of the C-terminal
domain of MPK10 orthologs from Trypanosomatidae generated
with Clustal-X and visualized with BioEdit. The phospho-serine
residue S395 is marked by the grey arrow and the conserved
DHMxRTxSxME motif is underlined. Color code: black, identical
residues; grey, similar residues; white, no conservation. B) Table of
percentage of protein sequence identity of MPK10 from L.
donovani compared to other Leishmania species. The following
strains were aligned LmjF, L. major Friedlin; LmxM, L. mexicana
MHOM/GT2001/U1103; LinJ, L. infantum JPCM5; LdBPK, L.
donovani BPK282A1; LbrM, L. braziliensis MHOM/BR/75/
M2904; LtaP, L. tarentolae Parrot-TarlI; Tb, T. brucei; Tbg, T.
brucei gambiense DAL972; TcIL3000, T. congolense IL3000;
TcCLB, T. cruzi CL Brener; TCSYLVIO, T. cruzi Sylvio X10/1;
Tc_MARK, T. cruzi marinlellei strain B7; TvY486, T. vivax
Y486.
(TIF)
Figure S4 Table of the p-values for the kinetic analysis of kinase
activity plotted in Figure 3B. Results of three independent
experiments were subjected to statistical analysis using a student’s
t-test or Mann-Whitney Sum Rank test. Equal gray level of the
cells corresponds to equal p-value. Dark grey, p-value,0.001; light
grey, p-value,0.01; white, p-value,0.05, NS, non significant.
(TIF)
Figure S5 Recombinant MPK10 is not phosphorylated on
Y192. GFP-MPK10 and GST-Strep-MPK10 NM and -K/A
proteins were purified from amastigotes at 48 h during axenic
differentiation and recombinant bacteria, respectively, and
analyzed by western blotting using anti-phospho-tyrosine (a-pTyr)
and anti-MPK10 (a-MPK10) antibodies.
(TIF)
Figure S6 MPK10 mutations do not affect promastigote growth
and viability. The analysis represents the combined results of three
triplicate experiments. 26105 promastigotes were cultured during
8 days and aliquots were taken every 24 h for analysis. Cell
number and percent of cell death were assessed by flow cytometry.
Upper panel: Untransfected Control, UC (dotted line, open
squares); GFP-MPK10, NM (grey line, grey circles); GFP-MPK10-
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K51A, K/A (black line, open triangles). Lower panel:
GFP-MPK10-T190A, T/A (black line, black triangles); GFP-
MPK10-Y192F, Y/F (black line, white diamond); GFP-MPK10-
T190A_Y192F, T/A_Y/F (black line, black diamond). Each point
of the line graph represents the mean of three independent
triplicate experiments, with standard deviations denoted by error
bars.
(TIF)
Figure S7 Overexpression of empty vector has only a slight
effect on amastigote viability. The analysis represents one triplicate
experiment. 16106 amastigotes were cultured during 8 days and
aliquots were taken every 24 h for analysis. Cell number and
percent of cell death were assessed by flow cytometry. Upper
panel: Untransfected Control, UC (dotted line, open squares);
GFP-MPK10, NM (grey line, grey circles); pXG-mock, mock
(black line, black circles). Each point of the line graph represents
the mean of three independent triplicate experiments, with
standard deviations denoted by error bars.
(TIF)
Figure S8 LC-MS/MS analysis of Leishmania total protein
extracts from amastigotes. The samples were subjected to
phosphoproteomic analysis following titanium dioxide phospho-
peptide enrichment and iTRAQ labeling. MS/MS raw data
spectra of identified peptides presenting phosphorylation of
threonine and tyrosine of the TxY motif (A), and phosphorylation
of serine 395 located inside the carboxy terminal extension of
MPK10 (B) are shown.
(TIF)
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